Add like
Add dislike
Add to saved papers

Life events, caregiving, and risk of autoimmune rheumatic diseases in the Women's Health Initiative Observational Study.

BACKGROUND: Growing evidence suggests psychosocial stressors may increase risk of developing autoimmune disease. We examined stressful life events and caregiving in relation to incident Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) in the Women's Health Initiative Observational Study cohort.

METHODS: The sample of post-menopausal women included 211 incident RA or SLE cases reported within 3 years after enrollment, confirmed by use of disease modifying anti-rheumatic drugs (i.e., Probable RA/SLE), and 76,648 non-cases. Baseline questionnaires asked about life events in the past year, caregiving, and social support. We used Cox regression models to calculate Hazard Ratios (HR) and 95% Confidence Intervals (CI), adjusting for age, race/ethnicity, occupational class, education, pack-years smoking and BMI.

RESULTS: Incident RA/SLE was associated with having 3 or more life events (e.g., age-adjusted HR 1.70; 95%CI 1.14, 2.53; ptrend =0.0026). Elevated HRs were noted for physical (2.48; 1.02, 6.04) and verbal (1.34; 0.89, 2.02) abuse (ptrend =0.0614), 2 or more interpersonal events (1.23, 95%CI 0.87, 1.73; ptrend =0.2403), financial stress (1.22; 95%CI 0.90, 1.64), and caregiving 3 or more days per week (1.25; 95%CI 0.87, 1.81; ptrend =0.2571). Results were similar excluding women with baseline symptoms of depression or moderate to severe joint pain in the absence of diagnosed arthritis.

DISCUSSION: Our findings support the idea that diverse stressors may increase risk of developing probable RA or SLE in post-menopausal women, supporting the need for further studies in autoimmune rheumatic diseases including childhood adverse events, life event trajectories, and modifying psychosocial and socioeconomic factors. This article is protected by copyright. All rights reserved.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app